How useful is OCT in secondary progressive MS?

Specialists at ECTRIMS 2021 reported new data on optical coherence tomography (OCT) measures as biomarkers of disability progression in patients with secondary progressive MS (SPMS).

Dr Floriana De Angelis from Queen Square MS Centre at University College London, UK, presented findings from the MS-SMART trial cohort.